Four good reasons to appreciate triple positivity

Polskie Archiwum Medycyny Wewnetrznej

Volumn 126, Issue 1-2, 2016, Pages 7-8

  Pengo, Vittorio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CHEMOLUMINESCENCE; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; PRACTICE GUIDELINE; THROMBOEMBOLISM;

ANTIPHOSPHOLIPID SYNDROME; HUMANS;

EID: 84958236838     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.3253     Document Type: Editorial

References (12)

1. Iwaniec T, Kaczor MP, Celinska-Löwenhoff M, et al. Identification of patients with triple antiphospholipid antibody positivity is platform and method independent. Pol Arch Med Wewn. 2016; 126: 19-24.
2. Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010; 8: 237-242.
3. Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: A multicenter prospective study. Blood. 2011; 118: 4714-4718.
4. Pengo V, Biasiolo A, Pegoraro C, et al. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005; 93: 147-152.
5. Otomo K, Atsumi T, Amengual O, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012; 64: 504-512.
6. Sciascia S, Bertolaccini ML. Thrombotic risk assessment in APS: The Global APS Score (GAPSS). Lupus. 2014; 23: 1286-1287.
7. Pengo V, Ruffatti A, Del Ross T, et al. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile. J Thromb Haemost. 2013; 11: 1-5.
8. Pengo V, Biasiolo A, Rampazzo P, Brocco T. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-β2-glycoprotein-I autoantibodies. Thromb Haemost. 1999; 81: 256-258.
9. de Laat B, Pengo V, Pabinger I, et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: An international multicenter study. J Thromb Haemost. 2009; 7: 1767-1773.
10. Pengo V, Ruffatti A, Tonello M, et al. Antiphospholipid syndrome: Antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk. J Thromb Haemost. 2015; 13: 782-787.
11. Pengo V, Ruffatti A, Tonello M, et al. Antibodies to Domain 4/5 (Dm4/5) of β2-glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles. Thromb Res. 2015; 136: 161-163.
12. Bertolaccini ML, Amengual O, Andreoli L, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014; 13: 917-930.